Drug Type Small molecule drug |
Synonyms GEM-144, GEM144 |
Target |
Action inhibitors |
Mechanism HDAC11 inhibitors(histone deacetylase 11 inhibitors), POLA1 inhibitors(DNA polymerase alpha subunit inhibitors), Epigenetic drug |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colorectal Cancer | Preclinical | United States | 29 Apr 2025 | |
| Colorectal Cancer | Preclinical | Italy | 29 Apr 2025 | |
| Colorectal Cancer | Preclinical | Italy | 29 Apr 2025 | |
| Colorectal Cancer | Preclinical | Lebanon | 29 Apr 2025 |





